Invesco Ltd. - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 190 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q3 2023$1,030,149
-82.3%
302,985
-61.6%
0.00%
-100.0%
Q2 2023$5,805,434
-35.1%
789,855
-8.5%
0.00%0.0%
Q1 2023$8,943,570
-64.4%
863,279
-59.4%
0.00%
-71.4%
Q4 2022$25,115,371
+22.0%
2,126,619
+116.8%
0.01%0.0%
Q3 2022$20,592,000
-19.2%
981,075
+19.6%
0.01%
-12.5%
Q2 2022$25,471,000
-30.1%
820,599
-7.5%
0.01%
-11.1%
Q1 2022$36,435,000
-15.4%
887,362
-10.4%
0.01%
-10.0%
Q4 2021$43,047,000
+18.0%
990,262
+36.0%
0.01%
+11.1%
Q3 2021$36,466,000
-23.2%
728,307
-3.4%
0.01%
-25.0%
Q2 2021$47,483,000
-51.2%
753,829
-28.0%
0.01%
-53.8%
Q1 2021$97,257,000
+1.0%
1,046,791
-2.6%
0.03%
-7.1%
Q4 2020$96,326,000
+41.3%
1,075,074
+63.0%
0.03%
+21.7%
Q3 2020$68,148,000
+7.4%
659,527
-17.8%
0.02%0.0%
Q2 2020$63,425,000
+20.2%
802,037
-12.1%
0.02%
+4.5%
Q1 2020$52,781,000
+60.7%
912,224
+49.8%
0.02%
+120.0%
Q4 2019$32,844,000
-21.0%
608,797
-23.4%
0.01%
-9.1%
Q3 2019$41,576,000
-0.3%
795,261
-7.8%
0.01%0.0%
Q2 2019$41,685,000
+6.5%
862,865
+11.3%
0.01%
-15.4%
Q1 2019$39,157,000
-26.4%
775,066
-13.7%
0.01%
-35.0%
Q4 2018$53,209,000
-28.4%
897,588
-20.5%
0.02%
-13.0%
Q3 2018$74,351,000
+79.5%
1,129,433
+37.7%
0.02%
+64.3%
Q2 2018$41,416,000
+2.6%
820,294
+6.9%
0.01%
-6.7%
Q1 2018$40,386,000
+11.3%
767,076
-1.8%
0.02%
+15.4%
Q4 2017$36,294,000
+6.5%
781,031
-7.3%
0.01%0.0%
Q3 2017$34,091,000
+3.5%
842,810
-13.2%
0.01%
+30.0%
Q2 2017$32,940,000
+232.4%
971,376
+184.7%
0.01%
+233.3%
Q1 2017$9,909,000
-4.2%
341,203
+8.3%
0.00%0.0%
Q4 2016$10,344,000
-27.7%
314,978
-30.6%
0.00%
-40.0%
Q3 2016$14,305,000
+25.0%
453,690
+11.5%
0.01%
+25.0%
Q2 2016$11,442,000
-11.1%
406,928
+14.9%
0.00%
-20.0%
Q1 2016$12,875,000
-24.6%
354,188
-17.0%
0.01%
-28.6%
Q4 2015$17,066,000
+15.1%
426,546
-18.0%
0.01%
+16.7%
Q3 2015$14,824,000
-21.2%
520,310
-8.9%
0.01%
-14.3%
Q2 2015$18,820,000
+10.1%
571,197
-3.9%
0.01%0.0%
Q1 2015$17,096,000
+1.9%
594,448
-3.5%
0.01%
+16.7%
Q4 2014$16,780,000
+39.4%
616,251
+9.1%
0.01%
+20.0%
Q3 2014$12,035,000
-2.3%
564,757
+3.0%
0.01%0.0%
Q2 2014$12,316,000
-21.3%
548,349
-11.5%
0.01%
-16.7%
Q1 2014$15,652,000
+32.9%
619,401
+20.9%
0.01%
+20.0%
Q4 2013$11,777,000
+48.0%
512,295
+22.6%
0.01%
+66.7%
Q3 2013$7,960,000
+39.2%
417,852
+5.4%
0.00%0.0%
Q2 2013$5,717,000396,4600.00%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Laurus Investment Counsel Inc. 120,504$10,797,0004.20%
SNYDER CAPITAL MANAGEMENT L P 723,477$64,824,0002.12%
Hillcrest Asset Management LLC 161,428$14,464,0001.97%
RICE HALL JAMES & ASSOCIATES, LLC 587,727$52,660,0001.85%
PALISADE CAPITAL MANAGEMENT, LP 579,009$51,879,0001.33%
Pier Capital, LLC 109,786$9,837,0001.04%
Paradiem, LLC 21,320$2,286,0000.97%
EARNEST PARTNERS LLC 1,390,735$124,610,0000.86%
Ridgewood Investments LLC 10,004$1,034,0000.82%
Tygh Capital Management, Inc. 56,334$5,048,0000.78%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders